Inside the Minds of Other Biotech & Life Sciences CEO & Founders

• •identifying novel biological targets from grants, literature, and omics data
• •reducing cost of goods for cell therapies
• •achieving radical transparency in food origin
• •applying machine learning to make sense of vast genomic data
• •quantitatively tracking human performance improvements

+10 more PRO

• •diseases (cancer, heart issues, alzheimer's) are major killers
• •people covering their authentic selves, losing energy for problem-solving
• •the challenge for many cios to make the 'leap' to business roles
• •technologies don't allow for deterministic calling of bases
• •biology and medicine too diverse to create one-size-fits-all solutions

+10 more PRO

• •ability to 'replicate all those results' (reproducibility)
• •7 million people who are customers today
• •growth in childhood (metaphorical for scientific progress)
• •maintenance and integrity of the gut barrier
• •maintaining healthy regularity

+10 more PRO

• •expanding antigen targets (to cover more cancer types)
• •personal comfort level: people should wait until they are comfortable with genetic testing
• •first principle thinking - for measuring humans and closing the loop
• •what moves people - understanding emotional drivers in individuals
• •economical prevention: preventing illness is more cost-effective than waiting for treatment

+10 more PRO

• •lack of payment innovation for one-time treatments
• •reliance on 'gut/experience driven' methods for decision making
• •leaky gut and compromised epithelial barrier
• •believing things without critical thought
• •belief immune system had nothing to do with cancer (historical red flag)

+10 more PRO